M Holdings Securities’s XBiotech XBIT Stock Holding History

M Holdings Securities’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,733	Closed	-$139K	–	278
2016 Q4	$139K	Sell	13,733 -12,100	-47%	-$161K	0.05%	248
2016 Q3	$348K	Hold	25,833	–	–	0.16%	172
2016 Q2	$540K	Hold	25,833	–	–	0.28%	111
2016 Q1	$244K	Sell	25,833 -1,000	-4%	-$8.28K	0.15%	174
2015 Q4	$292K	Hold	26,833	–	–	0.2%	146
2015 Q3	$401K	Buy	26,833 +13,333	+99%	+$233K	0.29%	107
2015 Q2	$244K	Buy	+13,500	New	+$280K	0.16%	155

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIA

Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

M Holdings Securities's XBIT Position: Q1 2017 in Review

M Holdings Securities sold out of XBiotech (XBIT) in Q1 2017, closing a stake of 13,733 shares — an estimated $139K sold.

M Holdings Securities first reported a position in XBIT in Q2 2015 and held it in 7 quarters. The position peaked at $540K in Q2 2016. 48 funds tracked by Wall St. Rank hold XBIT as of Q1 2017.

M Holdings Securities reported no remaining XBiotech position as of Q1 2017 after selling out during the quarter.
M Holdings Securities sold 13,733 XBiotech shares in Q1 2017, an estimated $139K.
M Holdings Securities first reported a position in XBiotech in Q2 2015 and held it in 7 quarters.
M Holdings Securities's XBiotech position peaked at $540K in Q2 2016.
48 funds tracked by Wall St. Rank held XBiotech as of Q1 2017.

Based on M Holdings Securities's 13F filing for Q1 2017, filed 30 Jun 2017.